Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.75M 19.3M 17.71M 33.27M 2.28B 33.78M 229M 89.52M 1.12B 88.69M 86.78M 3.87B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 37.05M 34.46M 31.62M 59.41M 4.06B 60.32M 409M 160M 2B 158M 155M 6.91B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
04/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
15/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
Current month-14.63%
1 month-14.63%
3 months-16.67%
6 months-31.37%
Current year+6.06%
1 week 0
Extreme 0.0035
0
1 month 0
Extreme 0.0035
0
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
0.78
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-46.97%+218.18% 1.33M
-2.30%-6.28%+19.82%+423.99% 2.08B
-2.03%-2.54% - - 1.84B
-3.87%-2.79%-43.69%-61.76% 1.58B
-1.72%-5.68%+77.91%+493.99% 1.29B
-1.41%-2.56%-47.16%+38.28% 1.19B
-0.59%-0.78%+317.74%+913.08% 1.08B
-1.28%+3.46%+52.21%+29.26% 965M
-2.49%-12.60%+14.96%+29.16% 679M
-2.38%-6.82%-45.48%-91.16% 399M
Average -1.81%-3.61%+33.26%+221.45% 1.11B
Weighted average by Cap. -2.08%-3.69%+43.26%+265.64%

Financials

2015 2016
Net sales 25.48M 22.38M 20.81M 19.1M 35.88M 2.45B 36.44M 247M 96.56M 1.21B 95.66M 93.59M 4.17B 32.33M 28.4M 26.41M 24.23M 45.53M 3.11B 46.23M 314M 123M 1.53B 121M 119M 5.29B
Net income 5.49M 4.83M 4.49M 4.12M 7.74M 529M 7.86M 53.29M 20.82M 260M 20.63M 20.18M 899M 2.06M 1.81M 1.68M 1.54M 2.9M 198M 2.95M 19.99M 7.81M 97.59M 7.74M 7.57M 337M
Net Debt 24.8M 21.79M 20.26M 18.59M 34.93M 2.39B 35.47M 241M 93.99M 1.17B 93.12M 91.11M 4.06B 18.56M 16.3M 15.16M 13.91M 26.14M 1.79B 26.54M 180M 70.33M 879M 69.67M 68.17M 3.04B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
346
Date Price Change Volume
24/07/26 $0.003500 0.00% 2,070
  1. Stock Market
  2. Stocks
  3. AOXG Stock